Invention Application
- Patent Title: ADENOVIRUS POLYNUCLEOTIDES AND POLYPEPTIDES
-
Application No.: US17565796Application Date: 2021-12-30
-
Publication No.: US20220204566A1Publication Date: 2022-06-30
- Inventor: Stefano COLLOCA , Virginia AMMENDOLA , Fabiana GRAZIOLI , Alessandra Franz VITELLI , Alfredo NICOSIA , Riccardo CORTESE
- Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- Priority: EPPCT/EP2015/063248 20150612,GB1510357.5 20150612,GB1514772.1 20150819
- Main IPC: C07K14/005
- IPC: C07K14/005 ; C12N15/86 ; C07K14/075 ; C07K14/75 ; A61K39/12 ; C12N15/861 ; A61K39/155 ; A61K39/21 ; C12N7/00
Abstract:
There is provided inter alia an isolated polynucleotide, wherein the polynucleotide encodes a polypeptide selected from the group consisting of: (a) a polypeptide having the amino acid sequence according to SEQ ID NO: 1, (b) a functional derivative of a polypeptide having the amino acid sequence according to SEQ ID NO: 1, wherein the functional derivative has an amino acid sequence which is at least 80% identical over its entire length to the amino acid sequence of SEQ ID NO: 1, and (c) a polypeptide having the amino acid sequence according to SEQ ID NO: 3.
Information query
